| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| NAFLD | Non-alcoholic fatty liver disease |
| MASH | Metabolic dysfunction-associated steatohepatitis |
| MetS | Metabolic syndrome |
| n-3 PUFA | Omega-3 polyunsaturated fatty acids |
| EPA | Eicosapentaenoic acid |
| DHA | Docosahexaenoic acid |
| DIO + DHA | DHA supplementation in diet-induced obese |
| DIO | Diet-induced obese |
| HFD | High fat diet |
| ALT | Alanine aminotransferase |
| PCA | Principal component analysis |
| DEGs | Differentially expressed genes |
| Log2FC | Log2 fold change |
| rRNA | Ribosomal RNA |
| TEC | Type still to be experimentally confirmed |
| PPI | Protein–protein interaction |
| GO | Gene Ontology |
| GSEA | Gene Set Enrichment Analysis |
| Ppargc1a | Peroxisome proliferator-activated receptor gamma coactivator 1-alpha |
| Acsl5 | Acyl-CoA synthetase long chain family member 5 |
| Hadhb | Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta |
| MTP | Mitochondrial trifunctional protein |
| Fgf21 | Fibroblast growth factor 21 |
| Egr1 | Early growth response 1 |
| Dgat2 | Diacylglycerol acyltransferase 2 |
| Ces1 | Carboxylesterase 1 |
| Lepr | Leptin receptor |
| Saa | Serum amyloid A |
| FN1 | Fibronectin 1 |
| Hmox1 | Heme oxygenase 1 |
| FFAs | Free fatty acids |
| FO | Fish oil |
| ER | Endoplasmic reticulum |
| IR | Insulin resistance |
| Fwd | Forward |
| Rev | Reverse |
| nt | Nucleotide |